← k3vl4r
Log inGet started →

NAMS (NewAmsterdam Pharma Company NV) Price Forecast

AI-generated price forecast for NewAmsterdam Pharma Company NV (NAMS) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of October 2026: K3vl4r's calibrated AI forecast currently reads NAMS as 1/1 bearish across its horizons (0 of 1 timeframes pointing up), with a last price of 21.15. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

21.15

AI outlook

1/1 bearish

Timeframes up

0 / 1

Share𝕏PostTelegram

NAMS forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▼ Down-27.29%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called NAMS's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Latest NAMS news

From the market-news feed the forecasts are read against.

  • Does NewAmsterdam Pharma’s (NAMS) Genotype-Targeted SPINOZA Trial Reframe Obicetrapib’s Long-Term Alzheimer’s Strategy? · Yahoo · Oct 13
  • RBC Capital Maintains Outperform on NewAmsterdam Pharma Co, Lowers Price Target to $42 · Benzinga · Oct 5
  • NewAmsterdam Pharma (NASDAQ:NAMS) Stock Falls 5.2% on Insider Selling · ldr:americanbankingnews.com · Oct 4
  • NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Yahoo · Oct 2
  • NewAmsterdam Pharma (NASDAQ:NAMS) Stock Price Down 5.2% - Time to Sell? · ldr:marketbeat.com · Oct 2

🔒

See the full NAMS forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

NAMS forecast — frequently asked

Will NAMS go up?

K3vl4r's calibrated AI forecast currently reads NAMS as 1/1 bearish — 0 of 1 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the NAMS price prediction for 2026?

K3vl4r's model projects NAMS toward $15.69 over the next ~4 weeks, a -27.3% move from $21.58. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

NEOONMDTWSTSTOKADMAVERANAGEALGNDSGNDYNELVNIRONRLMDQTTB

Will NAMS reach…?

Will NAMS reach $25.00?Will NAMS reach $50.00?Will NAMS reach $100.00?

Or see the full NAMS price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare NAMS

NAMS vs NEONAMS vs ONMDNAMS vs TWSTNAMS vs STOKNAMS vs ADMANAMS vs VERA

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.